The company
Indivior Pharmaceuticals, Inc.
INDV · Nasdaq
INDV stood above a rising 150-day average in 42 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 6.8% below that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 3
- Industry in uptrend
- 32% -7 in 4 wk
- Insider buys, 12 months
- $623K
- Insider sales, 12 months
- $5.7M
- Officials’ trades on record
- 6
- Institutions holding
- 311 (+43)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 42 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
6 disclosed lines: House 0, Senate 0, executive 6; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 4 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $50k–$100k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $50k–$100k | 26 Feb 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 30 Jan 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Woodrow D. AndersonChief Accounting Officer | bought | 1,500at $35.69 | 27 Aug 2026filed 27 Aug 2026 |
| Woodrow D. AndersonChief Accounting Officer | bought | 1,500at $36.28 | 5 Aug 2026filed 5 Aug 2026 |
| Christian HeidbrederChief Scientific Officer | sold | 18,586at $41.14 | 10 Jul 2026filed 13 Jul 2026 |
| Christian HeidbrederChief Scientific Officer | sold | 18,586at $38.06 | 11 Jun 2026filed 12 Jun 2026 |
| Ryan PreblickChief Financial Officer | sold | 36,000at $37.70 | 8 Jun 2026filed 10 Jun 2026 |
| Barbara RyanDirector | bought | 8at $31.09 | 13 Mar 2026filed 13 Mar 2026 |
| Barbara RyanDirector | bought | 31at $32.56 | 9 Mar 2026filed 11 Mar 2026 |
| Stuart A. KingsleyDirector | bought | 940at $31.87 | 6 Mar 2026filed 11 Mar 2026 |
| Daniel A. NinivaggiDirector | bought | 775at $35.39 | 5 Jan 2026filed 7 Jan 2026 |
| Mark StejbachDirector | bought | 775at $35.39 | 5 Jan 2026filed 7 Jan 2026 |
| David E. WheadonDirector | bought | 1,771at $35.39 | 5 Jan 2026filed 7 Jan 2026 |
| Barbara RyanDirector | bought | 775at $35.39 | 5 Jan 2026filed 7 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 18,709,432$767.6M | +167,212+0.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 7,572,287$310.7M | -319,532−4.0% |
| OAKTREE CAPITAL MANAGEMENT LPnew · filed 14 Aug 2026 | 6,127,212$251.4M | +6,127,212 |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 5,495,486$225.5M | -91,090−1.6% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 4,992,071$204.8M | +88,078+1.8% |
| FULLER & THALER ASSET MANAGEMENT, INC.added · filed 12 Aug 2026 | 4,615,816$189.4M | +86,233+1.9% |
| Two Seas Capital LPreduced · filed 12 Aug 2026 | 3,479,493$142.8M | -1,267,017−26.7% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 3,395,702$139.3M | -110,115−3.1% |
| FRANKLIN RESOURCES INCadded · filed 13 Aug 2026 | 3,316,358$136.1M | +3,204,765+2871.8% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 3,159,866$129.7M | +234,178+8.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.